Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Keppra	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Scheduled	O
Therapy	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
male	O
with	O
a	O
history	O
of	O
GBM	O
who	O
is	O
admitted	O
for	O
treatment	O
with	O
NovoTTF.	O
The	O
patient	O
is	O
unable	O
to	O
provide	O
any	O
history	O
due	O
to	O
aphasia	O
due	O
to	O
his	O
GBM.	O
Therefore	O
all	O
history	O
obtained	O
from	O
records	O
and	O
discuss	O
with	O
his	O
primary	O
neurological	O
oncologist.	O
The	O
patient	O
recently	O
started	O
treatment	O
with	O
avastin	O
on	O
___.	O
He	O
is	O
now	O
admitted	O
to	O
receive	O
treatment	O
with	O
NovoTTF	O
which	O
he	O
will	O
receive	O
for	O
a	O
week	O
at	O
a	O
time	O
and	O
will	O
alternate	O
with	O
a	O
week	O
off.	O
Past	O
Medical	O
History:	O
-	O
COPD	O
-	O
Alcohol	O
Abuse	O
-	O
Hypertension	O
Social	O
History:	O
___	O
Family	O
History:	O
Unable	O
to	O
obtain.	O
Physical	O
Exam:	O
Admission:	O
PHYSICAL	O
EXAM:	O
General:	O
Agitated	B-Unspecified_cognitive_impairment
VITAL	O
SIGNS:	O
BP	O
114/68	O
HR	O
66	O
RR	O
19	O
O2	O
96%RA	O
HEENT:	O
MMM,	O
no	O
OP	O
lesions	O
CV:	O
RR,	O
NL	O
S1S2	O
PULM:	O
CTAB	O
ABD:	O
Soft,	O
NTND,	O
no	O
masses	O
or	O
hepatosplenomegaly	O
LIMBS:	O
No	O
edema.	O
SKIN:	O
No	O
rashes	O
or	O
skin	O
breakdown	O
NEURO:	O
Alert,	O
oriented	O
to	O
person	O
only,	O
unable	O
to	O
follow	O
commands/participate	O
in	O
exam.	O
Aphasia.	O
Discharge:	O
General:	O
NAD,	O
sitting	O
in	O
bed,	O
appears	O
comfortable	O
Eyes:	O
PERRLA	O
HEENT:	O
MMM,	O
no	O
OP	O
lesions	O
CV:	O
RRR	O
no	O
m/r/g,	O
warm	O
and	O
well	O
perfused	O
distal	O
extremities,	O
no	O
edema	O
PULM:	O
CTAB	O
anteriorly	O
only	O
as	O
could	O
not	O
roll	O
over	O
given	O
shackles,	O
normal	O
respiratory	O
rate,	O
no	O
increased	O
work	O
of	O
breathing	O
ABD:	O
Soft,	O
NTND,	O
no	O
masses	O
or	O
hepatosplenomegaly	O
LIMBS:	O
No	O
edema.	O
shackles	O
on	O
both	O
legs	O
and	O
right	O
arm	O
SKIN:	O
No	O
rashes	O
or	O
skin	O
breakdown	O
NEURO:	O
AOx1	B-Unspecified_cognitive_impairment
(himself	O
only,	O
could	O
not	O
name	O
hospital	O
unless	O
I	O
help	O
with	O
first	O
word),	O
speaks	O
in	O
short	O
sentences	O
but	O
not	O
meaningful	O
ones,	O
can	O
follow	O
simple	O
commands	O
like	O
opening	O
eyes	O
Access:	O
Right	O
chest	O
port	O
with	O
c/d/I	O
dressing	O
in	O
place	O
Pertinent	O
Results:	O
___	O
05:16AM	O
BLOOD	O
WBC-6.2	O
RBC-4.24*	O
Hgb-13.4*	O
Hct-39.2*	O
MCV-93	O
MCH-31.6	O
MCHC-34.2	O
RDW-12.6	O
RDWSD-42.7	O
Plt	O
___	O
___	O
05:16AM	O
BLOOD	O
___	O
PTT-33.6	O
___	O
___	O
05:16AM	O
BLOOD	O
Glucose-133*	O
UreaN-10	O
Creat-0.7	O
Na-143	O
K-4.1	O
Cl-106	O
HCO3-24	O
AnGap-13	O
___	O
05:16AM	O
BLOOD	O
Calcium-8.3*	O
Phos-2.7	O
Mg-2.1	O
Micro:	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
Imaging:	O
None	O
Brief	O
Hospital	O
Course:	O
___	O
PMH	O
of	O
GBM	O
admitted	O
for	O
scheduled	O
therapy	O
with	O
optune	O
and	O
bevacizumab.	O
Patient	O
received	O
optune	O
treatment	O
for	O
1	O
week,	O
and	O
received	O
dose	O
of	O
Bevacizumab	O
(C1D14)	O
on	O
___	O
prior	O
to	O
discharge.	O
He	O
is	O
to	O
start	O
colchicine	O
in	O
the	O
outpatient	O
setting	O
to	O
prepare	O
his	O
malignancy	O
for	O
his	O
next	O
cycle	O
of	O
optune	O
treatments	O
to	O
begin	O
on	O
___.	O
Colchicine	O
will	O
be	O
dosed	O
in	O
outpatient	O
setting	O
only.	O
He	O
is	O
to	O
receive	O
next	O
dose	O
of	O
bevacizumab	O
on	O
the	O
___	O
day	O
of	O
his	O
next	O
optune	O
treatment.	O
Patient	O
will	O
continue	O
such	O
regimen	O
indefinitely	O
at	O
this	O
point,	O
until	O
directed	O
otherwise	O
by	O
Dr.	O
___.	O
Transitional	O
Issues:	O
1.	O
Continue	O
daily	O
colchicine	O
until	O
next	O
inpatient	O
optune	O
treatment	O
on	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Labetalol	O
100	O
mg	O
PO	O
BID	O
2.	O
Phenytoin	O
Sodium	O
Extended	O
400	O
mg	O
PO	O
QHS	O
3.	O
Thiamine	O
100	O
mg	O
PO	O
DAILY	O
4.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
5.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Colchicine	O
0.6	O
mg	O
PO	O
DAILY	O
start	O
on	O
___	O
RX	O
*colchicine	O
0.6	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
daily	O
when	O
outpatient	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Labetalol	O
100	O
mg	O
PO	O
BID	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
5.	O
Phenytoin	O
Sodium	O
Extended	O
400	O
mg	O
PO	O
QHS	O
6.	O
Thiamine	O
100	O
mg	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Glioblastoma	O
Chronic	O
Encephalopathy	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Unspecified_cognitive_impairment
-	O
always.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
while	O
you	O
were	O
hospitalized.	O
You	O
were	O
hospitalized	O
for	O
your	O
chemotherapy	O
and	O
optune	O
treatments.	O
You	O
tolerated	O
the	O
treatments	O
well.	O
You	O
will	O
return	O
on	O
___	O
for	O
your	O
next	O
cycle.	O
You	O
should	O
take	O
colchicine	O
in	O
the	O
outpatient	O
setting	O
to	O
prepare	O
for	O
your	O
next	O
cycle.	O
In	O
the	O
future	O
you	O
will	O
take	O
this	O
medication	O
only	O
on	O
the	O
weeks	O
you	O
are	O
not	O
hospitalized	O
for	O
your	O
optune	O
treatments.	O
Followup	O
Instructions:	O
___	O

